HIGH-DENSITY OF SOMATOSTATIN RECEPTORS IN VEINS SURROUNDING HUMAN CANCER-TISSUE - ROLE IN TUMOR-HOST INTERACTION

被引:120
作者
REUBI, JC
HORISBERGER, U
LAISSUE, J
机构
[1] Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Berne
关键词
D O I
10.1002/ijc.2910560513
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Somatostatin receptors were detected in peritumoral veins of various human cancer tissue specimens. Vascular and neoplastic tissue from 14 colonic adenocarcinomas, 13 carcinoids, 6 renal-cell carcinomas and 7 malignant lymphomas ware analyzed form somatostatin receptors by use of quantitative receptor autoradiography. In colonic carcinoma specimens, the peritumoral vessels expressed a high density of somatostatin receptors, whereas the neoplastic tissue itself was receptor-negative in many cases. In contrast, the incidence and density of somatostatin receptors in peritumoral vessels was low in well-differentiated gastrointestinal and bronchial carcinoids, in contrast to the high density of such receptors in the carcinoid tumor tissue. Autochthonous vessels surrounding other tumors such as renal-cell carcinomas or malignant lymphomas also frequently expressed somatostatin receptors. In all cases, the somatostatin receptors were localized in veins, particulary in the smooth-muscle cell layer. They exhibited specific and high-affinity binding of somatostatin-14, somatostatin-28 and octreotide, suggesting a preferential expression of the SSTR2 receptor subtype. Since the vessels of normal non-neoplastic human tissues, e.g. of intestine or lymphatic organs, have few somatostatin receptors, the increased somatostatin receptor expression in peritumoral vessels observed in this study may be linked to the neoplastic process itself. The results suggest that somatostatin and somatostatin receptors may play a regulatory role for hemodynamic tumor-host interactions, possibly involving tumor stroma generation, tumor environment, angiogenesis and, particularly, vascular drainage of poorly differentiated neoplasms. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:681 / 688
页数:8
相关论文
共 26 条
[1]  
FOLKMAN J, 1993, CANCER MED, V1, P153
[2]   THE EFFECT OF LONG-ACTING SOMATOSTATIN ANALOG SMS-201.995 THERAPY ON TUMOR KINETIC MEASUREMENTS AND SERUM TUMOR-MARKER CONCENTRATIONS IN PRIMARY RECTAL-CANCER [J].
IFTIKHAR, SY ;
WATSON, SA ;
MORRIS, DL .
BRITISH JOURNAL OF CANCER, 1991, 63 (06) :971-974
[3]   LYMPHOCYTIC INFILTRATION AND SURVIVAL IN RECTAL-CANCER [J].
JASS, JR .
JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (06) :585-589
[4]   THE ROLE OF SOMATOSTATIN AND ITS ANALOGS IN THE DIAGNOSIS AND TREATMENT OF TUMORS [J].
LAMBERTS, SWJ ;
KRENNING, EP ;
REUBI, JC .
ENDOCRINE REVIEWS, 1991, 12 (04) :450-482
[5]  
MANTYH PW, 1991, ADV EXP MED BIOL, V298, P253
[6]   EFFECTS OF A SOMATOSTATIN ANALOG (SMS 201-995) ON THE GROWTH AND DEVELOPMENT OF HEPATIC TUMOR DERIVED BY INTRAPORTAL INJECTION OF WALKER CELLS IN THE RAT [J].
NOTT, DM ;
BAXTER, JN ;
YATES, J ;
GRIME, JS ;
DAY, DW ;
COOKE, TG ;
JENKINS, SA .
BRITISH JOURNAL OF SURGERY, 1989, 76 (11) :1149-1151
[7]  
PREVOST G, 1992, CANCER RES, V52, P843
[8]  
RADULOVIC SS, 1992, P SOC EXP BIOL MED, V200, P394
[9]   SOMATOSTATIN .1. [J].
REICHLIN, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (24) :1495-1501
[10]  
REUBI JC, 1993, BLOOD, V82, P2143